02:31 PM EDT, 03/14/2024 (MT Newswires) -- Spruce Biosciences ( SPRB ) slumped 81% after top-line results from its CAHmelia-203 study of tildacerfont in adult classic congenital adrenal hyperplasia with severe hyperandrogenemia failed to meet its primary efficacy endpoint.

More than 15 million shares traded intraday compared with a daily average of about 395,000.

Fisker ( FSR ) has hired advisers to help prepare for a possible bankruptcy filing, the Wall Street Journal reported.

Shares sank 55% as intraday trading volume soared to more than 262 million from a daily average of about 55.2 million.

RumbleOn ( RMBL ) reported Thursday a narrowing in Q4 loss amid lower revenue.

Shares dropped 24%, with intraday trading volume at over 1.21 million compared with a daily average of about 171,000.

Price: 0.97, Change: -4.22, Percent Change: -81.36